BRIEF-Argent Biopharma To Acquire Core Operating Assets And IP Portfolio Of Auscann Group

Reuters
Aug 19, 2025
BRIEF-Argent Biopharma To Acquire Core Operating Assets And IP Portfolio Of Auscann Group

Aug 19 (Reuters) - Argent BioPharma Ltd RGT.AX:

  • BINDING TERM SHEET TO ACQUIRE CORE OPERATING ASSETS AND IP PORTFOLIO OF AUSCANN GROUP HOLDINGS

  • WILL ISSUE AC8 25 MILLION ORDINARY SHARES, VALUED AT USD 15 MILLION

Further company coverage: RGT.AX

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10